• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Vu Q&A

Vu Q&A

August 23, 2024

HepVu’s One Question Series on Viral Hepatitis Elimination: RNA HCV Testing

May 29, 2024

Harvard's Center for Health Law and Policy Innovation (CHLPI) on Incarcerated Individuals and Access to Healthcare

Read More

May 22, 2024

The Hep B Foundation on Hepatitis B Treatment Guidelines

Read More

May 22, 2024

Thaddeus Pham on Hepatitis B in AAPI Communities

Read More

May 7, 2024

Dr. Howard Koh on the Public Health Workforce Crisis

Read More

April 2, 2024

Hepatitis C Elimination and the Cherokee Nation

Read More

December 20, 2023

Frank Hood on Hepatitis B and the Importance of Viral Hepatitis Surveillance

Read More

November 1, 2023

HepVu and NASTAD on the Viral Hepatitis Surveillance Status Report and New Trends

Read More

September 19, 2023

Dr. Jagpreet Chhatwal on the White House’s Plan to Eliminate Hepatitis C

Read More

August 8, 2023

Dr. Samuel So on Global Hepatitis B Elimination Efforts

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 5

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.